PrinterPrezz enticed the Berkeley Catalyst Fund in a series A round that will help expand its medical device 3D printing business.
PrinterPrezz, a US-based medical device 3D printing technology developer, closed a $16m series A round yesterday with investors including Berkeley Catalyst Fund, a venture unit aligned to University of California (UC) Berkeley.
DOV Singularity Fund, an investment unit of D.One Vision Management, led the round with participation from Solvay Ventures on behalf of chemicals producer Solvay and venture capital firm Boutique Venture Partners.
Founded in 2018, PrinterPrezz has developed an end-to-end ecosystem to design, prototype and 3D print…
